Definition of S-3304 - National Cancer Institute Drug Dictionary

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Search for

Starts with

Contains

All

S-3304
An orally-agent agent with potential antineoplastic activity. S-3304 inhibits matrix metalloproteinases (MMPs), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. Check for or using this agent. ()

Previous:	RP-Mycin, Rubidomycin, rubitecan, ruthenium Ru 106, S-1
Next:	S-adenosyl-L-methionine disulfate p-toluene-sulfonate, S-CKD602, sabarubicin, safingol, Salagen